关于维生素D摄入量与癌症之间的关系的综合评论
Matthias Schömann-Finck1, Thomas Vogt2, Jörg Reichrath2
1German University of Applied Sciences for Prevention and Health Management, Saarbrücken, Germany; m-schoemann-finck@dhfpg-bsa.de.
Anticancer research
|March 4, 2025
概括
摄入维生素D可以帮助预防乳腺癌,结肠直肠癌和肺癌,降低结肠直肠癌的死亡率. 然而,对其他癌症的证据不一致,需要对维生素D和癌症进行更多的研究.
科学领域:
- 在瘤学瘤学.
- 营养科学 营养科学
- 公共卫生 公共卫生
背景情况:
- 癌症是欧盟主要的死亡原因.
- 维生素D缺乏通过各种机制与癌症的发展有关.
- 目前对维生素D骨外作用的研究往往忽略了它在癌症中的作用.
研究的目的:
- 审查维生素D摄入量与五种主要癌症 (乳腺癌,结直肠癌,肺癌,胰腺癌和前列腺癌) 之间的关联.
- 综合当前关于维生素D在预防癌症和减少死亡率方面的潜在作用的证据.
主要方法:
- 总体评论和观察性研究的文献综述.
- 对维生素D摄入量 (饮食和补充剂) 的数据分析.
- 专注于乳腺,结肠直肠,肺,胰腺和前列腺癌的发病率和死亡率.
主要成果:
- 维生素D摄入量显示了潜在的预防性作用,用于乳腺癌,结肠直肠癌和肺癌.
- 随着维生素D的摄入,人们观察到结直肠癌死亡率可能减少.
- 其他癌症的结论不确定;没有关于胰腺癌和肺癌死亡率的数据.
结论:
- 摄入维生素D可能有助于预防某些癌症并降低死亡率.
- 目前的证据受到观察性研究设计和方法学挑战的限制.
- 进一步进行高质量的研究对于确定因果关系和澄清维生素D在癌症中的作用至关重要.
相关概念视频
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
Connective Tissue Cell Types
3.1K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.1K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer Survival Analysis
319
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
319
Mutations
32.9K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
32.9K
Dose-Response Relationship: Overview
2.9K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
2.9K


